Fennec Pharmaceuticals Inc Q4 Loss Decreases, Beats Estimates
(RTTNews) - Fennec Pharmaceuticals Inc (FENC) released Loss for fourth quarter that decreased from last year and beat the Street estimates.
The company's earnings totaled -$1.62 million, or -$0.06 per share. This compares with -$2.68 million, or -$0.10 per share, last year.
Analysts on average had expected the company to earn -$0.13 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period fell 18.6% to $7.93 million from $9.74 million last year.
Fennec Pharmaceuticals Inc earnings at a glance (GAAP) :
-Earnings: -$1.62 Mln. vs. -$2.68 Mln. last year. -EPS: -$0.06 vs. -$0.10 last year. -Revenue: $7.93 Mln vs. $9.74 Mln last year.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.